BSEBoard Meeting6d ago · 4 Nov 2026, 05:11 pm

Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Financial result for the quarter and half year ended on September 30, 2026 along with Limited Review Report thereof.

Omkar Pharmachem Ltd · 532167

✦ AI SummaryResults

Omkar Pharmachem Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 to consider and approve Unaudited Financial result for the quarter and half year ended on September 30, 2026 along with Limited Review Report thereof.

Analysis Scores

Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact9/10
Market Sentiment6/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Omkar Pharmachem Ltd - 532167 - Board Meeting Intimation for Intimation Of The Board Meeting Of The Company Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Attachments (1)

📄

9bb0e4b5-406c-42be-b555-76e1ef12f180.pdf

pdf

Download →
View document text
L& 7 39 Ombkar DPharmachem L 8. Date: 04.11.2026 BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001 Sub: Intimation of the Board Meeting of the Corapany Under Regulation 29(1)(A) of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Company Scrip Code: 532167 Dear Sir(s), Pursuant to Regulations 29(1)(a) of SEBI (LODR) Regulations 2015 notice is hercby given that a meeting of Board of Directors of Omkar Pharmachem Limited will be held on Saturday, 14" Day of November, 2026 at 04:30 P.M. at the registered office of the Company inter :lia; To consider, approve and take on record the Unaudited Financial Results of the Company for the Quarter and half year encicd on 30" September, 2026. Further, in continuation to our Intimation dated September 26, 2026 regarding closure of trading window for dealing in chares of the Company, we hereby inform you that pursuant to the Code of Conduct to Regulate, Monitor and Report Trading in Securities of the Company, the trading window for dealing in shares of the Company shall continue to remain closed till November 16, 2026, (inclusive) for all the Designated Persons of i Company and their Immediate Relatives. Thanking you, Yours faithfully, For Omkar Pharmachem Limited Digitally signed by B HAWA N BHAWANI'S GOYAL Date: 2026.11.04 I S GOYAL 16:05:28 +05'30' Bhawani S Goyal (Managing Director) DIN: 03255804 Address: Ward No-03, Nangal Chaudhry, Narnaul, Mahendragarh, Haryana-123023 Off,= Il Street-1, Near Gujja ral College Cross Road, Ellisbri dge Ahmmeedca bad-380006, GJ, Ph.: 971181116 - CIN: E;gf)gr}?‘SJ‘JQGSPLCU%QTS, Email: investors.opl@gmail.com, Website: www.omkarpharmachem co.in